← Back to Clinical Trials
Recruiting NCT05566353

Telemonitoring in Cochlear Implant Patient Care

Trial Parameters

Condition Hearing Loss
Sponsor University Hospital, Montpellier
Study Type INTERVENTIONAL
Phase N/A
Enrollment 78
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2022-12-20
Completion 2025-06-20
Interventions
Remote Check

Brief Summary

Following a sufficient delay after the cochlear implantation and initial implant activation, the patient will return to the hospital for follow-up visits for equipment maintenance and auditory performance evaluation only once per year. This frequency might appear either insufficient, in which case an additional patient check-up will be arranged, or excessive if patient performances and implant adjustments are stable. Using at-home testing tool for remote hearing performance monitoring can thus appear advantageous for both patients and clinicians, allowing to avoid an unnecessary journey to the implantation reference center for the first and to diminish a number of unscheduled medical appointments for the second.

Eligibility Criteria

Inclusion Criteria: * Subjects-users of uni- or bilateral cochlear implants (Cl24RE, series 400, 500 and 600) and Cochlear Nucleus processor CP1000 or CP1150 during one year minimum * Subjects who have already renewed their processor at least once * Subjects implanted for more than 5 years * Over 20 years old * Subjects with Apple or Android smartphones compatible with Remote Check Exclusion criteria: * Associated physical (visual, motor...) or severe cognitive (dementia, specific language development troubles) making impossible the use of smartphone software and the conduction of hearing tests * Patients unable to give oral informed consent * Patients residing in geographical zones with limited internet access * Subjects deprived of liberty by juridical or administrative decision * Patients subjected to legal protection measures (guardianship or curatorship) * Subjects for whom French is not a native language

Related Trials